Cantor Fitzgerald Bolsters Healthcare and Biotechnology Equity Research Team with Addition of Josh Schimmer, M.D., and Eric Schmidt, Ph.D.

/PRNewswire/ -- Cantor Fitzgerald, L.P., ("Cantor") a leading global financial services firm, today announced the addition of Josh Schimmer, M.D., and Eric...

Related Keywords

United States ,Toronto ,Ontario ,Canada ,New York ,America ,Pascal Bandelier ,Howardw Lutnick ,Eric Schmidt ,Piper Jaffrey ,Josh Schimmer ,Prnewswire Cantor Fitzgerald ,University Of Toronto ,Cantor Fitzgerald ,Reuters ,Cowen Co ,Harvard Business School ,Massachusetts Institute Of Technology ,Cantor Fitzgerald Co ,Biotechnology Research ,Corporate Development ,Evercore Biotechnology Research Team ,Nasdaq ,Committee For The Department Of Biology ,University Of Pennsylvania ,America Research Team ,Allogene Therapeutics Inc ,Senior Research Analyst ,Federal Reserve Bank ,Senior Managing Director ,Investment Banking ,Biotechnology Research Team ,Institutional Investor ,All America Research Team ,Lazard Capital Markets ,Leerink Partners ,Harvard Business ,Allogene Therapeutics ,Chief Financial Officer ,Alpha Magazine ,Wall Street ,Allogene Overland Biopharm ,Notch Therapeutics ,Relmada Therapeutics ,Massachusetts Institute ,Visiting Committee ,Prime Services ,Asset Management ,Commercial Real Estate ,Chief Executive Officer ,Help ,